Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
Condition: ObesityInterventions: Drug: Canagliflozin; Drug: Phentermine; Drug: Matching Placebo to Canagliflozin; Drug: Matching Placebo to PhentermineSponsor: Janssen Research & Development, LLCRecruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adipex | Canagliflozin | Diabetes | Eating Disorders & Weight Management | Endocrinology | Invokana | Obesity | Phentermine | Research